FSTX - F-star Therapeutics GAAP EPS of -$1.88 beats by $0.37 revenue of $21.17M beats by $5.85M
F-star Therapeutics press release (NASDAQ:FSTX): FY GAAP EPS of -$1.88 beats by $0.37. Revenue of $21.17M (+88.0% Y/Y) beats by $5.85M. Cash and cash equivalents of $78.5M for the year ended December 31, 2021, compared to $18.5M for the year ended December 31, 2020.
For further details see:
F-star Therapeutics GAAP EPS of -$1.88 beats by $0.37, revenue of $21.17M beats by $5.85M